Teen Fighting for Those with Dementia Through Innovative New Treatments
source: pixabay.com

Teen Fighting for Those with Dementia Through Innovative New Treatments

by Lauren Taylor from In The Cloud Copy After completing an internship at the world-renowned Cleveland Clinic, one Ohio teenager is now working on changing the world for dementia patients…

Continue Reading Teen Fighting for Those with Dementia Through Innovative New Treatments
Overview of Coping Mechanisms That Can Help with Isolation-Induced Depression
source: pixabay.com

Overview of Coping Mechanisms That Can Help with Isolation-Induced Depression

by Caitlin Seida from In The Cloud Copy Isolation as a result of COVID-19 precautions is necessary but can take its toll on your physical, mental, emotional, and spiritual well-being.…

Continue Reading Overview of Coping Mechanisms That Can Help with Isolation-Induced Depression
Can Wnt Activation Treat Aggressive Medulloblastoma Subtypes?
source: pixabay.com

Can Wnt Activation Treat Aggressive Medulloblastoma Subtypes?

According to Genetic Engineering & Biotechnology News, researchers recently discovered a potential therapy for patients with aggressive subtypes of medulloblastoma. There are four subtypes of this condition. The first is…

Continue Reading Can Wnt Activation Treat Aggressive Medulloblastoma Subtypes?
CUTX-101 Shows Promise for Menkes Disease
https://pixabay.com/en/copper-scrap-metal-scrap-disposal-1504098/

CUTX-101 Shows Promise for Menkes Disease

Recently, biopharmaceutical company Fortress Biotech announced positive clinical results for CUTX-101 (copper histidinate). The data highlights the efficacy of CUTX-101 for patients with Menkes disease. As there are currently no…

Continue Reading CUTX-101 Shows Promise for Menkes Disease
Preclinical Data Supports NurOwn for ALS, MS, and Alzheimer’s Disease
Source: Pixabay

Preclinical Data Supports NurOwn for ALS, MS, and Alzheimer’s Disease

  Within the last month, BrainStorm Cell Therapeutics Inc. announced the publication of pre-clinical data on the NurOwn system. NurOwn technology produces autologous, bone marrow-derived mesenchymal stem cells (MSCs) for…

Continue Reading Preclinical Data Supports NurOwn for ALS, MS, and Alzheimer’s Disease
Close Menu